Feasibility, Impact on Symptoms and Mentalising Capacity

This pilot study aimed to evaluate the feasibility of an assessor-blind, randomised controlled trial of psychodynamic art therapy for the treatment of patients with schizophrenia, and to generate preliminary data on the efficacy of this intervention during acute psychotic episodes. Fifty-eight inpatients with DSM-diagnoses of schizophrenia were randomised to either 12 twice-weekly sessions of psychodynamic group art therapy plus treatment as usual or to standard treatment alone. Primary outcome criteria were positive and negative psychotic and depressive symptoms as well as global assessment of functioning. Secondary outcomes were mentalising function, estimated with the Reading the mind in the eyes test and the Levels of emotional awareness scale, self- efficacy, locus of control, quality of life and satisfaction with care. Assessments were made at baseline, at post-treatment and at 12 weeks' follow- up. At 12 weeks, 55% of patients randomised to art therapy, and 66% of patients receiving treatment as usual were examined. In the per-protocol sample, art therapy was associated with a significantly greater mean reduction of positive symptoms and improved psychosocial functioning at post-treatment and follow-up, and with a greater mean reduction of negative symptoms at follow-up compared to standard treatment. The significant reduction of positive symptoms at post-treatment was maintained in an attempted intention- to-treat analysis. There were no group differences regarding depressive symptoms. Of secondary outcome parameters, patients in the art therapy group showed a significant improvement in levels of emotional awareness, and particularly in their ability to reflect about others' emotional mental states. This is one of the first randomised controlled trials on psychodynamic group art therapy for patients with acute psychotic episodes receiving hospital treatment. Results prove the feasibility of trials on art therapy during acute psychotic episodes and justify further research to substantiate preliminary positive results regarding symptom reduction and the recovery of mentalising function

Дослідження структури порушених відкритою розробкою земель й пошук шляхів вдосконалення рекультивації залишкових виробок кар'єрів

Стаття присвячена дослідженням структури порушених земель, на ділянках з видобутку корисних копалин відкритим способом. Наведено площі порушень земель при розробці основних видів корисних копалин. Проаналізовано ризики, що виникають із несвоєчасною рекультивацією земель гірничого відводу, а також від покинутих гірничих виробок старих кар'єрів. Паралельно розглянуті обсяги відходів гірничого виробництва та їх повторне використання в якості заповнювача для залишкових вироблених просторів кар'єрів.The article is devoted to the research of land violation indicators at the extraction of minerals by surface mining method. Data gives about the land violations area at the mining key minerals. Ana-lyzed the risks from the not-on-time reclamation of the mining clam and abandoned excavations of the old quarries. In parallel considered the volumes of mining wastes and their reuse as aggregate for filling residual spaces of surface mines.Статья посвящена исследованиям площадей нарушения земель, связанных с добычей полезных ископаемых открытым способом. Приведены площади нарушений земель при разработке основных видов полезных ископаемых. Проанализированы риски, представляемые несвоевременной рекультивацией земель горного отвода, а также заброшенными горными выработками старых карьеров. Параллельно рассмотрены объемы отходов горного производства и их повторное использование в качестве заполнителя для остаточных выработанных пространств карьеров

A Pilot RCT of Psychodynamic Group Art Therapy for Patients in Acute Psychotic Episodes: Feasibility, Impact on Symptoms and Mentalising Capacity

<div><p></p><p>This pilot study aimed to evaluate the feasibility of an assessor-blind, randomised controlled trial of psychodynamic art therapy for the treatment of patients with schizophrenia, and to generate preliminary data on the efficacy of this intervention during acute psychotic episodes. Fifty-eight inpatients with DSM-diagnoses of schizophrenia were randomised to either 12 twice-weekly sessions of psychodynamic group art therapy plus treatment as usual or to standard treatment alone. Primary outcome criteria were positive and negative psychotic and depressive symptoms as well as global assessment of functioning. Secondary outcomes were mentalising function, estimated with the Reading the mind in the eyes test and the Levels of emotional awareness scale, self-efficacy, locus of control, quality of life and satisfaction with care. Assessments were made at baseline, at post-treatment and at 12 weeks' follow-up. At 12 weeks, 55% of patients randomised to art therapy, and 66% of patients receiving treatment as usual were examined. In the per-protocol sample, art therapy was associated with a significantly greater mean reduction of positive symptoms and improved psychosocial functioning at post-treatment and follow-up, and with a greater mean reduction of negative symptoms at follow-up compared to standard treatment. The significant reduction of positive symptoms at post-treatment was maintained in an attempted intention-to-treat analysis. There were no group differences regarding depressive symptoms. Of secondary outcome parameters, patients in the art therapy group showed a significant improvement in levels of emotional awareness, and particularly in their ability to reflect about others' emotional mental states. This is one of the first randomised controlled trials on psychodynamic group art therapy for patients with acute psychotic episodes receiving hospital treatment. Results prove the feasibility of trials on art therapy during acute psychotic episodes and justify further research to substantiate preliminary positive results regarding symptom reduction and the recovery of mentalising function.</p><p>Trial Registration</p><p>ClinicalTrials.gov <a href="http://www.clinicaltrials.gov/ct2/show/NCT01622166" target="_blank">NCT01622166</a></p></div

Means, standard deviations, and group comparisons between art therapy and treatment as usual for psychopathological symptoms (SAPS, SANS, CDSS) and global assessment of functioning (GAF) in per-protocol and intention-to-treat samples at post-treatment and follow-up visits.

1<p>: n_AT = 16/n_TAU = 19;</p>2<p>: n_AT = 16/n_TAU = 20;</p>3<p>: n_AT = 24/n_TAU = 29.</p><p>Per-protocol sample: ANCOVA factors: intervention, gender; covariates: verbal IQ, baseline value of dependent variable; F_[df]; *: p<0.05; **: p<0.01; η²_p; corrected p-value (Bonferroni) p<0.0125 (significant results underlined).</p><p>Intention-to treat sample: descriptive statistics and ANCOVA on multiply imputed data (m = 50): covariates: intervention, baseline value of dependent variable; pooled F_[df]; *: p<0.05; ^†: p = 0.078 (AT: art therapy; TAU: treatment as usual; SANS: Scale for the assessment of negative symptoms; SAPS: Scale for the assessment of positive symptoms; CDSS: Calgary depression scale for schizophrenia; GAF: Global assessment of functioning).</p><p>Means, standard deviations, and group comparisons between art therapy and treatment as usual for psychopathological symptoms (SAPS, SANS, CDSS) and global assessment of functioning (GAF) in per-protocol and intention-to-treat samples at post-treatment and follow-up visits.</p

CONSORT 2010 flow diagram.

<p>CONSORT 2010 flow diagram.</p

Means, standard deviations, group differences (F_[df]) and effect sizes (η²_p) between art therapy and treatment as usual for social cognition (LEAS, RME), self-efficacy/locus of control (FKK), quality of life (MSQoL) and satisfaction with care (ZUF-8) scores in the per-protocol sample.

1<p>: n_AT = 16/n_TAU = 20;</p>2<p>: n_AT = 16/n_TAU = 19;</p>3<p>: ANCOVA factors: intervention, gender; covariates: verbal IQ, AVLT^(1–5), baseline value of dependent variable.</p>4<p>: ANCOVA factors: intervention, gender; covariates: verbal IQ, baseline value of dependent variable; (post hoc) F_[df]; *: p<0.05; corrected p-value (Bonferroni) p<0.007.</p><p>(LEAS: Levels of Emotional Awareness Scale; RME: Reading the Mind in the Eyes Test; FKK SKI: sum score self-efficacy; FKK PC: sum score externality; MSQoL: Modular system for quality of life; ZUF-8: satisfaction with care).</p><p>Means, standard deviations, group differences (F_[df]) and effect sizes (η^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0112348#nt110" target="_blank">2</a>}_p) between art therapy and treatment as usual for social cognition (LEAS, RME), self-efficacy/locus of control (FKK), quality of life (MSQoL) and satisfaction with care (ZUF-8) scores in the per-protocol sample.</p

Baseline demographic and neuropsychological parameters, and illness characteristics in patients receiving art therapy or treatment as usual.

<p>T-test for independent samples;</p>1<p>: χ²-test;</p><p>*: p<005 (AT: art therapy; TAU: treatment as usual; AVLT: Auditory verbal learning test; CPZ equiv.: antipsychotic dose converted to chlorpromazine equivalents).</p><p>Baseline demographic and neuropsychological parameters, and illness characteristics in patients receiving art therapy or treatment as usual.</p

Composite follicular lymphoma and nodular lymphocyte predominance Hodgkin's disease.

Case ReportsJournal ArticleSCOPUS: le.jinfo:eu-repo/semantics/publishe